Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
1348 results
D1.148 - Real-world effectiveness of dupilumab administered every 4 weeks in patients with moderate to severe asthma
D1.149 - Healthcare Professionals Typically Apply Higher Blood Eosinophil Count Thresholds for Biologic Selection Versus Clinical Guidelines in Severe Asthma
D1.150 - Patient characteristics and treatment patterns in adults with severe asthma in Poland (POLSAR): a retrospective, single-center real-world cohort from ISAR
D1.152 - Treatment-induced remission after mepolizumab discontinuation: case series
D1.153 - Indirect Comparison of Biological Agents in Severe Asthma: Real-World Data
D1.154 - Mepolizumab treatment in a patient with severe eosinophilic granulomatosis with polyangiitis: a case report
D1.155 - Clinical, Functional and Inflammatory Characteristics of Young Adults with Bronchial Asthma Using Conventional Cigarettes, Electronic Nicotine Delivery Systems and Heated Tobacco Products
D1.156 - High relevance of upper airways comorbidities in T2 asthma inflammatory burden
D1.157 - Response to biologic therapy in severe asthma and chronic rhinosinusitis with nasal polyps according to nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity
D1.159 - Comorbidity of Asthma in Chronic Spontaneous Urticaria: Prevalence and Immunological Insights from a Sri Lankan Cohort
D1.160 - Perceptions, Attitudes, and Real-World Use of FENO in Allergy and Asthma Practice: Results of a National Survey from Türkiye
D1.161 - Clinical-epidemiological profile of pediatric difficult-to-control asthma in a tertiary referral center in Brazil
D1.164 - Evaluation of the use of cyclooxygenase-2 inhibitors in patients with AERD
D1.165 - Asthma Predisposition and miRNA Expression in Children with Recurrent Infections
D1.166 - REX-8756 is a First-in-Class Potent and Selective Orthosteric STAT6 Inhibitor That Demonstrates Efficacious Potential and Safety Differentiation in TH2-Mediated Inflammation
D1.167 - Galectin-3 and Airway Remodelling: Diagnostic and Prognostic Implications in Children
D1.168 - ASSOCIATION BETWEEN MOLECULAR ALLERGEN SENSITIZATION AND FeNO IN CHILDREN WITH ALLERGIC ASTHMA
D1.17 - Service Evaluation of patients with Suspected Allergic Reactions presenting to the Emergency Department of a tertiary Irish teaching hospital
D2.180 - Direct Cost of Occupational Asthma in the Textile industry: Evidence from the private sector in central Tunisia
D1.171 - Real-World Exacerbation Outcomes After AIR Therapy Rescue Implementation: Toward a SABA-Free Era
Pagination
First page
First
Previous page
Previous
…
Page
23
Page
24
Page
25
Page
26
Current page
27
Page
28
Page
29
Page
30
Page
31
…
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download